Biogen INC (BIIB) Holding Has Boosted by Clearbridge Investments Llc

Marco Green
December 15, 2017

The institutional investor held 6,278 shares of the consumer services company at the end of 2017Q2, valued at $306,000, down from 55,065 at the end of the previous reported quarter. The stock decreased 1.38% or $0.14 during the last trading session, reaching $10.01. About 1.14M shares traded or 3.26% up from the average. GlobalSCAPE, Inc. (NYSEAMERICAN:GSB) has risen 40.31% since December 14, 2016 and is uptrending. It has outperformed by 9.01% the S&P500.

Clearbridge Investments Llc increased its stake in Biogen Inc (BIIB) by 1.9% based on its latest 2017Q2 regulatory filing with the SEC. Tekla Capital Management Llc bought 44,800 shares as the company's stock declined 13.45% while stock markets rallied. The stock decreased 2.17% or $7.16 during the last trading session, reaching $323.55. The stock was acquired at an average cost of $317.36 per share, with a total value of $9,520,800.00. Biogen Inc. (NASDAQ:BIIB) has risen 4.94% since December 14, 2016 and is uptrending. It has underperformed by 11.76% the S&P500. The company has a quick ratio of 1.90, a current ratio of 2.19 and a debt-to-equity ratio of 0.46. LLC raised its position in shares of Biogen by 84.8% during the 3rd quarter.

Corp cut its stake in shares of Biogen Inc (NASDAQ:BIIB) by 1.5% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. New Amsterdam Partners LLC NY raised its holdings in shares of Biogen by 0.8% in the 2nd quarter. Biogen Inc has a one year low of $244.28 and a one year high of $348.84. Wetherby Asset Mngmt Inc reported 0.14% stake. (NASDAQ:BIIB). Royal National Bank Of Scotland Grp Pcl invested in 1,037 shares. New Jersey Better Educational Savings Tru invested in 3,000 shares. Institutional investors and hedge funds own 88.30% of the company's stock. Neuberger Berman Gp Limited Liability Corporation has invested 0.01% in Biogen Inc. Glg Limited Liability Co reported 0.48% stake. Guggenheim Ltd Company reported 375,808 shares stake. Biogen Inc. now has $68.42 billion valuation. (NASDAQ:BIIB). Glg Lc stated it has 0.48% of its portfolio in Biogen Inc. (NASDAQ:BIIB) news were published by: which released: "Bet on Biogen Inc for Easy Profits Into the New Year" on November 21, 2017, also with their article: "Biogen Inc." published on November 21, 2017, published: "The case for Gilead Sciences" on November 18, 2017. (NASDAQ:BIIB). Parsons Capital Mngmt Inc Ri reported 1,643 shares. During the same quarter last year, the firm earned $5.19 earnings per share. analysts anticipate that Biogen will post 22.03 EPS for the current fiscal year. Therefore 68% are positive. Adecoagro S.A. had 4 analyst reports since September 28, 2015 according to SRatingsIntel. The rating was maintained by Morgan Stanley with "Overweight" on Monday, November 23. (NASDAQ:BIIB) on Monday, July 27 with "Buy" rating. Stifel Nicolaus maintained it with "Buy" rating and $430.0 target in Monday, October 23 report. (NASDAQ:BIIB) on Wednesday, September 13 with "Market Perform" rating. As per Tuesday, October 17, the company rating was upgraded by Mizuho. The firm earned "Buy" rating on Monday, November 27 by BMO Capital Markets. The firm earned "Neutral" rating on Friday, March 11 by Robert W. Baird. On Tuesday, December 8 the stock rating was initiated by Haywood Securities with "Buy". Therefore 25% are positive.

Analysts await Biogen Inc. As per Tuesday, January 5, the company rating was maintained by Oppenheimer. See DHI Group, Inc.

In other news, Director Alexander J. Denner purchased 30,000 shares of the firm's stock in a transaction on Wednesday, November 29th. Raymond James maintained the shares of BIIB in report on Thursday, December 29 with "Strong Buy" rating. The firm has "Buy" rating by H.C. Wainwright given on Wednesday, July 26. BMO Capital Markets maintained Lundin Gold Inc. (NYSE:CIT) rating on Thursday, July 27.

Among 4 analysts covering Lundin Gold (TSE:LUG), 4 have Buy rating, 0 Sell and 0 Hold. (TSE:LUG) on Wednesday, May 31 with "Outperform" rating.

Since October 19, 2017, it had 0 insider purchases, and 2 sales for $653,858 activity. Another trade for 1,460 shares valued at $65,700 was sold by Solk Steve. Its up 0.25, from 0.88 in 2017Q1. It turned negative, as 80 investors sold CIT shares while 121 reduced holdings. Bb&T Ltd Liability reported 12,989 shares. Apg Asset Mgmt Nv stated it has 0.11% in CIT Group Inc. Following the completion of the transaction, the vice president now owns 10,813 shares of the company's stock, valued at $3,135,770.

Tekla Capital Management Llc increased its stake in Biogen Inc. The biotechnology company reported $6.31 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $5.70 by $0.61. First Tru Advsrs Ltd Partnership owns 146,965 shares or 0.11% of their United States portfolio. Lakewood Capital Mgmt Ltd Partnership has invested 7.1% in CIT Group Inc. Ubs Asset Americas owns 829,144 shares. Moreover, Bankshares Of Montreal Can has 0.01% invested in CIT Group Inc. Home Depot Inc (NYSE:HD) was reduced too. Pomelo Capital Ltd Co invested in 0.09% or 40,000 shares. Public Employees Retirement System of OH owned about 0.07% of Biogen worth $46,035,000 as of its most recent SEC filing.

Other reports by Click Lancashire

Discuss This Article